Core Viewpoint - The company has approved its 2025 semi-annual report and related proposals during the board meetings, including a share buyback plan and governance structure revisions [3][9][19]. Group 1: Company Overview - The company is Guangdong DeGuan Film New Materials Co., Ltd., with the stock code 001378 [7]. - The board of directors and the supervisory board have both confirmed the accuracy and completeness of the information disclosed [7][29]. Group 2: Financial and Operational Highlights - The company plans to repurchase shares using its own funds and a special loan for stock repurchase, with a total amount between RMB 20 million and RMB 40 million, and a maximum price of RMB 32.44 per share [5][19]. - As of June 30, 2025, the company has not yet implemented the share buyback [6]. Group 3: Board Meeting Resolutions - The board approved the 2025 semi-annual report and its summary, as well as a special report on the use of raised funds [9][12]. - The board has decided to revise the company's articles of association, eliminating the supervisory board and transferring its powers to the audit committee [14][17]. - The board approved the extension of certain fundraising project deadlines, specifically for the "Functional Film and Functional Masterbatch Expansion and Technical Transformation Project" and the "Laboratory and Testing Upgrade Technical Transformation Project" [19][32]. Group 4: Profit Distribution - The wholly-owned subsidiary, Guangdong DeGuan Packaging Materials Co., Ltd., plans to distribute RMB 100 million in profits to the company, which represents 17.52% of its distributable profits as of June 30, 2025 [22]. Group 5: Upcoming Events - The company will hold its second extraordinary general meeting of 2025 on September 1, 2025 [25].

Group 1 - The company held its 11th meeting of the 2nd Supervisory Board on May 29, 2025, with all three supervisors present, including one via remote communication [1] - The meeting was convened by the chairman of the Supervisory Board, Song Huijiang, and attended by some senior management personnel [1] - The meeting complied with the relevant laws, regulations, and the company's articles of association [1] Group 2 - The Supervisory Board reviewed and approved the proposal to terminate a fundraising project related to the production of semiconductor testing and sorting machine components, deciding to manage the remaining funds in a dedicated account [2] - The decision was deemed reasonable based on the implementation status of fundraising projects and the company's operational situation, aligning with legal regulations and the company's development strategy [2] - The voting result was unanimous with 3 votes in favor, and the proposal will be submitted for review at the company's first extraordinary general meeting of shareholders in 2025 [2]

登录新浪财经APP 搜索【信披】查看更多考评等级 二、通过深交所交易系统投票的程序 1. 投票的时间：2025年5月22日的交易时间，即上午9:15－9:25，9:30－11:30和13:00-15:00 2. 股东可以登录证券公司交易客户端通过交易系统投票。 三、通过深交所互联网投票系统的投票程序 1. 投票时间：2025年5月22日9:15-15:00 2. 股东通过互联网投票系统进行网络投票，需按照《深圳证券交易所投资者网络服务身份认证业务指 引》的规定办理身份认证，取得"深交所数字证书"或"深交所投资者服务密码"。具体身份认证流程可登 录互联网投票系统http://wltp.cninfo.com.cn规则指引栏目查阅。 3. 股东根据获取的服务密码或数字证书，可登录http://wltp.cninfo.com.cn在规定时间内通过深交所互联 网投票系统进行投票。 附件2 辽宁何氏眼科医院集团股份有限公司 2024年年度股东大会授权委托书 辽宁何氏眼科医院集团股份有限公司： 兹委托 先生/女士代表本人/本公司出席辽宁何氏眼科医院集团股份有限公司2024年年度股东大会并代为 行使表决权。授权期限自委托书签 ...